Auto-SCT Beats Allo-SCT for Relapsed Myeloma
Second Stem Cell Transplant Outperforms Allogeneic Option for Relapsed Multiple Myeloma, Study Finds For patients battling multiple myeloma, a second autologous stem cell transplant (auto-SCT) is proving to be a more effective strategy against relapse than previously thought, according to a comprehensive new review of existing data. The findings challenge long-held beliefs and suggest that … Read more